Live from the NIH registry
Studies recruiting near Lexington right now
Top 25 of 473 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Baptist Health Lexington — Lexington, Kentucky (3.8 mi)
· Sponsor: SWOG Cancer Research Network
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Lexington, Kentucky (3.8 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Associates of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Genentech, Inc.
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Amgen
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Baptist Health - Lexington — Lexington, Kentucky (3.8 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Baptist Health Lexington — Lexington, Kentucky (3.8 mi)
· Sponsor: Hoffmann-La Roche
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Baptist Health Lexington ( Site 0127) — Lexington, Kentucky (3.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Lexington, Kentucky (3.8 mi)
· Sponsor: Sameek Roychowdhury
Methadone for Post-operative Spine Surgery
Pain, Postoperative
Phase 4
Interventional 30 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Brandon Knopp
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: AB Science
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Saint Joseph Hospital — Lexington, Kentucky (3.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
University of Kentucky Markey Cancer Center ( Site 0019) — Lexington, Kentucky (3.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Colorectal Cancer, Pancreatic Cancer
N/A
Interventional 178 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Reema A. Patel
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment
Lung Cancer
N/A
Interventional 234 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Laurie McLouth
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
Cancer, Health Care Utilization
N/A
Interventional 300 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Timothy Mullett
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Lexington, Kentucky (3.8 mi)
· Sponsor: TG Therapeutics, Inc.
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial
Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8
N/A
Interventional 1,000 participants sought
University of Kentucky/Markey Cancer Center — Lexington, Kentucky (3.8 mi)
· Sponsor: OHSU Knight Cancer Institute
Methamphetamine and Troriluzole
Methamphetamine Use Disorder
EARLY/Phase 1
Interventional 40 participants sought
Psychopharmacology of Addiction Laboratory — Lexington, Kentucky (3.8 mi)
· Sponsor: William Stoops
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of Kentucky — Lexington, Kentucky (3.8 mi)
· Sponsor: Kura Oncology, Inc.
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Baptist Health Lexington /ID# 252769 — Lexington, Kentucky (3.8 mi)
· Sponsor: AbbVie
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Multiple conditions
Phase 1
Interventional 46 participants sought
University of Kentucky/Markey Cancer Center — Lexington, Kentucky (3.8 mi)
· Sponsor: National Cancer Institute (NCI)
Imatinib TDM in GIST
Gastrointestinal Stromal Tumors
Phase 2
Interventional 28 participants sought
Markey Cancer Center — Lexington, Kentucky (3.8 mi)
· Sponsor: Reema A. Patel
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Saint Joseph Hospital — Lexington, Kentucky (3.8 mi)
· Sponsor: NRG Oncology
Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal Cord Injury: A Pilot Study
Spinal Cord Stimulation, Electric Stimulation Therapy
N/A
Interventional 30 participants sought
University of Kentucky - Chandler Medical Center — Lexington, Kentucky (3.8 mi)
· Sponsor: Francis Farhadi
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
CommonSpirit Saint Joseph Medical Center - East Lexington — Lexington, Kentucky (3.8 mi)
· Sponsor: NRG Oncology